OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
63 hedge funds and large institutions have $44.4M invested in OncoMed Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
63
Holding in Top 10
–
Calls
$13K
Puts
–
Top Buyers
| 1 | +$760K | |
| 2 | +$254K | |
| 3 | +$189K | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$186K |
| 5 |
BP
BBR Partners
New York
|
+$142K |
Top Sellers
| 1 | -$740K | |
| 2 | -$364K | |
| 3 | -$355K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$174K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$142K |